Intelligence coverage: 65%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

CRIS

CURIS INC

Healthcare · Biotechnology

$1.00Sep 22, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

CURIS INC shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -100% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue -100% YoY in Q2 FY2026

Pipeline evidence · 0d ago

AlphaOS Signals
Upgrade to Premium

Latest earnings · Q2 2026

Full CRIS earnings analysis

Reported figures for CURIS INC — research only, not investment advice.

Revenue YoY
-100.0%

Latest Intelligence

Updated

What happened recently for CURIS INC (CRIS) — events, not interpretation.

Event
Reported Q2 2026 revenue -100% YoY.
Also
Last session September 22, 2026 at $1.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

CURIS INC (CRIS)

Healthcare · Biotechnology

Investment Snapshot above is the primary AlphaOS analysis for CURIS INC — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biotechnology
Market cap:
$2.09M
Revenue:
$1.14M

CRIS earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow CURIS INC through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.